114 related articles for article (PubMed ID: 38616512)
21. PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.
Zhang Y; Zhou X; Cheng X; Hong X; Jiang X; Jing G; Chen K; Li Y
Neoplasma; 2022 Dec; 69(6):1338-1348. PubMed ID: 36305690
[TBL] [Abstract][Full Text] [Related]
22. YTHDF2 Regulates Cell Growth and Cycle by Facilitating KDM1A mRNA Stability.
Li X; Zhang K; Hu Y; Luo N
Am J Pathol; 2023 Apr; 193(4):442-455. PubMed ID: 36681189
[TBL] [Abstract][Full Text] [Related]
23. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m
Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ
J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306
[TBL] [Abstract][Full Text] [Related]
24. YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.
Bai X; Chen J; Zhang W; Zhou S; Dong L; Huang J; He X
Cancer Sci; 2023 Nov; 114(11):4299-4313. PubMed ID: 37700438
[TBL] [Abstract][Full Text] [Related]
25. Targeting YTHDF2 inhibits tumorigenesis of diffuse large B-cell lymphoma through ACER2-mediated ceramide catabolism.
Chen X; Lu T; Ding M; Cai Y; Yu Z; Zhou X; Wang X
J Adv Res; 2023 Oct; ():. PubMed ID: 37865189
[TBL] [Abstract][Full Text] [Related]
26. Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.
Du C; Lv C; Feng Y; Yu S
J Exp Clin Cancer Res; 2020 Oct; 39(1):223. PubMed ID: 33087165
[TBL] [Abstract][Full Text] [Related]
27. PHF5A facilitates the development and progression of gastric cancer through SKP2-mediated stabilization of FOS.
Zhang Z; Peng L; Yang W; Li B; Hua Y; Luo S
J Transl Med; 2023 Jan; 21(1):5. PubMed ID: 36609277
[TBL] [Abstract][Full Text] [Related]
28. Expression of RAP1B is associated with poor prognosis and promotes an aggressive phenotype in gastric cancer.
Yang Y; Li M; Yan Y; Zhang J; Sun K; Qu JK; Wang JS; Duan XY
Oncol Rep; 2015 Nov; 34(5):2385-94. PubMed ID: 26329876
[TBL] [Abstract][Full Text] [Related]
29. Zinc oxide nanoparticles reduce the chemoresistance of gastric cancer by inhibiting autophagy.
Miao YH; Mao LP; Cai XJ; Mo XY; Zhu QQ; Yang FT; Wang MH
World J Gastroenterol; 2021 Jul; 27(25):3851-3862. PubMed ID: 34321849
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer.
Gu Z; Li Y; Yang X; Yu M; Chen Z; Zhao C; Chen L; Wang L
J Hematol Oncol; 2018 Sep; 11(1):115. PubMed ID: 30217218
[TBL] [Abstract][Full Text] [Related]
31. YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells.
Chen J; Sun Y; Xu X; Wang D; He J; Zhou H; Lu Y; Zeng J; Du F; Gong A; Xu M
Cell Cycle; 2017; 16(23):2259-2271. PubMed ID: 29135329
[TBL] [Abstract][Full Text] [Related]
32. Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer.
Shang W; Xie Z; Lu F; Fang D; Tang T; Bi R; Chen L; Jiang L
Oxid Med Cell Longev; 2019; 2019():9291683. PubMed ID: 30911354
[TBL] [Abstract][Full Text] [Related]
33. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of LINC01857 Increases Sensitivity of Gastric Carcinoma Cells to Cisplatin.
Chen Y; Wu Y
Comput Math Methods Med; 2022; 2022():3325686. PubMed ID: 35602347
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
[TBL] [Abstract][Full Text] [Related]
36. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer.
Song J; Liu Y; Wang T; Li B; Zhang S
Biomed Pharmacother; 2020 Aug; 128():110246. PubMed ID: 32447210
[TBL] [Abstract][Full Text] [Related]
37. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
Liang Y; Zhang CD; Zhang C; Dai DQ
Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
[TBL] [Abstract][Full Text] [Related]
38. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
39. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway.
Zhong M; Zhou L; Fang Z; Yao YY; Zou JP; Xiong JP; Xiang XJ; Deng J
World J Gastroenterol; 2021 Jul; 27(26):4221-4235. PubMed ID: 34326621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]